MeSH D012769 - shock
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010335:Pathologic processes
0 Companies
0 Drugs
Success rate
D012769:Â
Shock
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Salix Pharmaceuticals | Hydrocortisone | Anusol |  | 1984-06-06 |  |  |
| Teva | Dopamine | Dopamine |  | 1991-10-23 |  |  |
| Hydrocortisone | Hydrocortisone |  | 1994-05-27 |  |  | |
| Hydrocortisone | Nogenic |  | 1988-04-04 |  |  | |
| Padagis | Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Bacitracin-neomycin-polymyxin W/ Hydrocortisone |  | 1982-01-01 |  |  |
| Hydrocortisone | Hydrocortisone |  | 2000-05-24 |  |  | |
| Hydrocortisone | Stie-cort |  | 1985-11-25 |  |  | |
| Taro Pharmaceutical | Hydrocortisone | Hydrocortisone |  | 1999-07-23 |  |  |
| Hydrocortisone | Hydrocortisone Acetic Acid |  | 1985-03-04 |  |  | |
| Hydrocortisone butyrate | Hydrocortisone Butyrate |  | 2004-01-14 |  |  | |
| Hydrocortisone | U-cort |  | 1988-06-13 |  |  | |
| Glenmark Pharmaceuticals | Hydrocortisone | Hydrocortisone |  | 2018-10-12 |  |  |
| Hydrocortisone butyrate | Hydrocortisone Butyrate |  | 2013-09-27 |  |  | |
| Viatris | Hydrocortisone | Cortifoam |  | 1982-02-10 |  |  |
| Mylan | Hydrocortisone, Pramoxine | Epifoam |  | 1982-01-01 |  |  |
| Norepinephrine | Norepinephrine |  | 2018-10-04 |  |  | |
| Hydrocortisone, Pramoxine | Proctofoam |  | 1982-01-01 |  |  | |
| Perrigo | Hydrocortisone | Hydrocortisone |  | 1982-01-01 |  |  |
| Lupin Research | Hydrocortisone | Hydrocortisone |  | 2019-08-15 |  |  |
| Hydrocortisone butyrate | Hydrocortisone Butyrate |  | 2018-08-17 |  |  | |
| Sandoz | Hydrocortisone | Hydrocortisone |  | 1982-01-01 |  |  |
| Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone |  | 1983-08-25 |  |  | |
| Norepinephrine | Norepinephrine |  | 2018-10-18 |  |  | |
| Hydrocortisone, Ciprofloxacin | Cipro |  | 1998-02-10 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
100%2/2
Phase 2
67%10/15
Phase 3
63%17/27
Approved: 8Overall Success rate: 42%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use